Table 1.
Description of patients included in this study
| Patient No. | Sex | Age at Sampling | Diagnosis | ANCA | Clinical Findings | Creatinine,a μmol/L | BP at Admission, mmHg | BVAS Score | Blood Sample Taken Before/After Start of Immunosuppressive Therapy |
|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 43 | HSP | — | Purpura, nephritis, arthritis | 89 | 170/100 | 15 | B |
| 2 | M | 16 | HSP | — | Purpura, arthritis | 69 | 122/70 | 3 | B |
| 3b | M | 80 | MPA | MPO | Rash, nephritis | 259 | 168/72 | 23 | B |
| 4 | M | 62 | GPA | PR3 | URT symptoms, pulmonary granuloma, temporal arteritis | 61 | 130/90 | 6 | B |
| 5b | F | 19 | SLE | — | Rash, myalgia, scleritis, nephritis | 62 | 110/60 | 17 | A |
| 6b | F | 76 | GPA | PR3 | Gingivitis, rhinitis, hematuria | 74 | 130/70 | 14 | B |
| 7b | F | 12 | GPA | PR3 MPO | Fever, arthralgia, nephritis | 312 | 120/70 | 15 | A |
| 8b | F | 61 | GPA | MPO | Polychondritis, cough, rhinitis, nephritis | 54 | 150/80 | 13 | B |
| 9 | M | 10 | HSP | — | Purpura, arthritis, nephritis | 47 | 102/60 | 7 | B |
| 10 | F | 51 | GPA | PR3 | Hemoptysis, cough, nephritis | 132 | 164/96 | 8 | A |
| 11 | M | 73 | MPA | MPO | Hearing loss, nephritis | 173 | 155/93 | 15 | A |
| 12 | F | 68 | GPA | PR3 | Myalgia, arthralgia, nephritis | 86 | 136/79 | 13 | A |
| 13 | F | 67 | MPA | MPO | Myalgia, confusion, nephritis | 148 | 130/60 | 22 | B |
| 14 | F | 9 | HSP | — | Purpura, myalgia, nephritis, arthritis | 51 | 110/62 | 18 | B |
| 15 | M | 13 | GPA | PR3 | Dyspnea, pulmonary infiltrates, arthralgia, nephritis | 84 | 120/70 | 24 | B |
| 16 | F | 17 | GPA | MPO | Dyspnea, myalgia, arthralgia, gastrointestinal symptoms, nephritis | 86 | 115/75 | 26 | B |
| 17 | F | 13 | GPA | PR3 | Myalgia, pansinusitis, exophthalmos, pulmonary infiltrates | 48 | 110/75 | 17 | B |
M, male; —, no ANCA detected; B, before; MPA, microscopic polyangiitis; MPO, myeloperoxidase; GPA, granulomatosis with polyangiitis; URT, upper respiratory tract; F, female; A, after.
Normal creatinine values of 45–90 μmol/L for women and 60–105 μmol/L for men.